Discover the differences between exosomes and PDRN, what to expect from skincare and professional treatments, and how to choose an option that fits your skin goals.

As PDRN (polydeoxyribonucleotide) products enter mainstream aesthetic practice, one of the most common questions practitioners ask is deceptively simple: for a given patient, should I use PDRN or a HA skin booster? The question is deceptive because it implies a binary choice where the more useful clinical framing is a spectrum — with most patients sitting somewhere in the middle where both could offer benefit, and the skill lying in knowing which mechanism addresses their dominant concern more directly.

Skin booster treatments have one of the highest patient satisfaction rates in aesthetic medicine — when the right patient is treated, with the right product, and with appropriate outcome expectations established at consultation. They also have one of the most predictable routes to patient dissatisfaction: treating a patient whose concern is structural volume loss with a treatment that addresses skin quality, or promising 'glowing, radiant skin' to a patient whose primary visible concern is a fat hernation or significant volume deficit that biorevitalisation cannot address.